| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 37,193 | 26,405 | 25,051 | 42,944 | | Cost of Revenue | 22,964 | 16,176 | 23,380 | 27,183 | | | Gross Profit | 14,229 | 10,229 | 1,671 | 15,761 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,483 | 13,498 | 13,085 | 14,047 | | Non Recurring |
-
| (844) | 844 |
-
| | Others | 677 | 425 | 444 | 474 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 69 | (2,850) | (12,702) | 1,240 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,415 | 80 | 43 | 44 | | Earnings Before Interest And Taxes | 1,484 | (2,770) | (12,659) | 1,284 | | Interest Expense | 268 | 128 | 140 | 220 | | Income Before Tax | 1,216 | (2,898) | (12,799) | 1,064 | | Income Tax Expense | 113 | (393) | (521) | 112 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,103 | (2,505) | (12,278) | 952 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,103 | (2,505) | (12,278) | 952 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,103 | ($2,505) | ($12,278) | $952 |
|
0.02% Nasdaq 
0.33%
Income Statement
